Fundz
Back to SEC Filings
10-QLOW RiskSTABLE

BALCHEM CORP

www.balchem.com
Filed: Oct 23, 2026 CIK: 0000009326Health Care
View original filing on SEC.gov

Executive Summary

Analysis of 10-Q filing content

Balchem's Q3 2026 10-Q reflects routine, stable operations with no material changes to risk factors and effective disclosure controls. The company continued executing its new $4,000,000-share December 2025 repurchase program, having bought back 513,406 shares since inception, and amended its credit agreement with JPMorgan in July 2026. No legal proceedings are expected to have a material adverse effect on financial position.

Key Takeaways

No material changes to risk factors since the 2025 Form 10-K

Disclosure controls and internal controls over financial reporting remain effective with no changes

3 more takeaways

Filing Overview

Form TypeQuarterly Report (10-Q)
Filing DateOct 23, 2026
Risk LevelLOW
TrendSTABLE
Confidence82%

What This Means

Quarterly Report: Interim filing with unaudited financial data for the quarter.

View Full Filing on SEC.govBrowse More Filings